Schistosomiasis — Assessing Progress toward the 2020 and 2025 Global Goals

Abstract

BACKGROUND: With the vision of "a world free of schistosomiasis," the World Health Organization (WHO) set ambitious goals of control of this debilitating disease and its elimination as a public health problem by 2020 and 2025, respectively. As these milestones become imminent, and if programs are to succeed, it is important to evaluate the WHO programmatic guidelines empirically. METHODS: infection. RESULTS: infection (in Burkina Faso, Burundi, and Rwanda within three treatment rounds). Intracountry variation was evident in the relationships between overall prevalence and heavy-intensity infection (stratified according to treatment rounds), a finding that highlights the challenges of using one metric to define control or elimination across all epidemiologic settings. CONCLUSIONS: These data suggest the need to reevaluate progress and treatment strategies in national schistosomiasis control programs more frequently, with local epidemiologic data taken into consideration, in order to determine the treatment effect and appropriate resource allocations and move closer to achieving the global goals. (Funded by the Children's Investment Fund Foundation and others.).

Shown for reading. Its publisher allows quoting it, not republishing it.

References 28

1. 1.

   WHO Schistosomiasis [Internet]. 2019 [cited 2019 Jun 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis

   Not in our library

2. 2.
   Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 · 2018

   No notice
3. 3.
   The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases · 2014

   No notice
4. 4.

   WHO | Schistosomiasis [Internet]. World Health Organization; 2018 [cited 2018 Aug 1]. Available from: https://www.who.int/schistosomiasis/en/

   Not in our library

5. 5.

   Hotez PJ Forgotten people, forgotten diseases: the neglected tropical diseases and their impact on global health and development. 2011;

   Not in our library

6. 6.

   Colley DG, Bustinduy AL, Secor WE, King CH Human schistosomiasis. Lancet 2014;6736(13):1–12.

   Not in our library10.1016/s0140-6736(13)61949-2 (opens in a new tab)

7. 7.

   WHO | Genital manifestations of schistosomiasis [Internet]. World Health Organization; 2016 [cited 2017 Jan 23]. Available from: https://www.who.int/schistosomiasis/genital_schistosomiasis/en/

   Not in our library

8. 8.

   Montresor A, Engels D, Ramsan M, Foum A, Savioli L Field test of the 'dose pole' for praziquantel in Zanzibar. Trans R Soc Trop Med Hyg 2002 [cited 2019 Jun 1];96(3):323–4. Available from: https://academic.oup.com/trstmh/article-lookup/doi/10.1016/S0035-9203(02)90111-2

   Not in our library10.1016/s0035-9203(02)90111-2 (opens in a new tab)

9. 9.

   WHO Helminth control in school age children A guide for control managers second edition. World Heal Organ 2011;

   Not in our library

10. 10.

    Webster JP, Molyneux DH, Hotez PJ, Fenwick A The contribution of mass drug administration to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci 2014;369(1645):20130434.

    Not in our library10.1098/rstb.2013.0434 (opens in a new tab)

11. 11.

    WHO Progress report 2001–2011 and strategic plan 2012–2020. 2013;

    Not in our library

12. 12.

    Stothard JR, Campbell SJ, Osei-Atweneboana MY, et al. Towards interruption of schistosomiasis transmission in sub-Saharan Africa: Developing an appropriate environmental surveillance framework to guide and to support "end game" interventions. Infect Dis Poverty 2017;6(1):2253–64.

    Not in our library10.1186/s40249-016-0215-9 (opens in a new tab)

13. 13.

    WHO Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. 2012;

    Not in our library

14. 14.

    Toor J, Alsallaq R, Truscott JE, et al. Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current world health organization guidelines? Clin Infect Dis 2018;66:S245–52.

    Not in our library10.1093/cid/ciy001 (opens in a new tab)

15. 15.

    Lumley T Analysis of complex survey samples. J Stat Softw 2004;9(1):1-19.

    Not in our library

16. 16.

    King CH It's Time to Dispel the Myth of "Asymptomatic" Schistosomiasis. PLoS Negl Trop Dis 2015;9(2):e0003504.

    Not in our library10.1371/journal.pntd.0003504 (opens in a new tab)

17. 17.
    Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration · 2016

    No notice
18. 18.

    Knowles SCL, Webster BL, Garba A, et al. Epidemiological Interactions between Urogenital and Intestinal Human Schistosomiasis in the Context of Praziquantel Treatment across Three West African Countries. PLoS Negl Trop Dis 2015;9(10).

    Not in our library10.1371/journal.pntd.0004019 (opens in a new tab)

19. 19.

    SCORE | POC-CCA [Internet]. [cited 2018 Mar 10]. Available from: https://score.uga.edu/projects/poc-cca/

    Not in our library

20. 20.

    Clements MN, Corstjens PLAM, Binder S, et al. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi. Parasites and Vectors 2018;11(1).

    Not in our library10.1186/s13071-018-2700-4 (opens in a new tab)

21. 21.

    Turner HC, Bettis AA, Dunn JC, et al. Economic Considerations for Moving beyond the Kato-Katz Technique for Diagnosing Intestinal Parasites As We Move Towards Elimination. Trends Parasitol. 2017;33(6):435–43.

    Not in our library10.1016/j.pt.2017.01.007 (opens in a new tab)

22. 22.

    Prada JM, Touloupou P, Adriko M, Tukahebwa EM, Lamberton PHL, Hollingsworth TD Understanding the relationship between egg-and antigen-based diagnostics of Schistosoma mansoni infection pre-and post-treatment in Uganda. Parasit Vectors 2018;11(1):21.

    Not in our library10.1186/s13071-017-2580-z (opens in a new tab)

23. 23.

    Kittur N, Castleman JD, Campbell CH, King CH, Colley DG Comparison of schistosoma mansoni prevalence and intensity of infection, as determined by the circulating cathodic antigen urine assay or by the kato-katz fecal assay: A systematic review. Am J Trop Med Hyg 2016;94(3):605–10.

    Not in our library10.4269/ajtmh.15-0725 (opens in a new tab)

24. 24.
    Sensitivity and Specificity of Multiple Kato-Katz Thick Smears and a Circulating Cathodic Antigen Test for Schistosoma mansoni Diagnosis Pre- and Post-repeated-Praziquantel Treatment · 2014

    No notice
25. 25.

    Pennance T, Person B, Muhsin MA, et al. Urogenital schistosomiasis transmission on Unguja Island, Zanzibar: Characterisation of persistent hot-spots. Parasit Vectors 2016;9(1).

    Not in our library10.1186/s13071-016-1847-0 (opens in a new tab)

26. 26.
    Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies · 2017

    No notice
27. 27.

    Kittur N, Binder S, Campbell CH, et al. Defining persistent hotspots: Areas that fail to decrease meaningfully in prevalence after multiple years of mass drug administration with praziquantel for control of schistosomiasis. Am J Trop Med Hyg 2017;97(6):1810–7.

    Not in our library10.4269/ajtmh.17-0368 (opens in a new tab)

28. 28.

    WHO | Trachoma Strategy [Internet]. World Health Organization; 2018 [cited 2019 Jun 1]. Available from: https://www.who.int/trachoma/strategy/en/

    Not in our library

Cited by papers we hold 4

• New global targets for NTDs in the WHO roadmap 2021–2030 · 2021
  No notice
• Elimination of schistosomiasis in China: Current status and future prospects. · 2021
  Not checked
• Revisiting density-dependent fecundity in schistosomes using sibship reconstruction. · 2021
  Not checked
• Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target · 2021
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.